跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PROVERA Medroxyprogesterone acetate 10mg tablet - TGA Drug Approval Details
Approvals
/
TGA
/
PROVERA Medroxyprogesterone acetate 10mg tablet
Approved
STANDARD
PROVERA Medroxyprogesterone acetate 10mg tablet
Pfizer Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
2a3e379e44021389
Company
Pfizer Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
2a3e379e44021389
Product Name
PROVERA Medroxyprogesterone acetate 10mg tablet
Artg Id
42934
Artg Name
PROVERA Medroxyprogesterone acetate 10mg tablet blister pack (new embossing)
Sponsor
Pfizer Australia Pty Ltd
Company Detail Path
/organization/pfizer-australia-pty-ltd
Artg Date
1993-01-07
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/4a28693d2996cb87523d45561e7ed575.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/d407657c88d10460ed36319a0adaea08.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
2a3e379e44021389
Type
Standard
Back to TGA Approvals